Large-scale dependency and drug screens to characterize the therapeutic vulnerabilities of multiple myeloma with 1q.
Sklavenitis-Pistofidis R, Lightbody ED, Reidy M, Tsuji J, Alberge JB, Aranha MP, Heilpern-Mallory D, Roweth HG, Huynh D, Chong SJF, Chung AY, Zhang J, Hackett L, Haradhvala NJ, Wu T, Su NK, Berrios B, Belkin S, Dutta AK, Knudson RA, Brandt C, Greipp PT, Davids MS, Papaioannou M, Getz G, Ghobrial IM, Manier S.
Sklavenitis-Pistofidis R, et al.
Blood. 2025 Jul 3;146(1):89-103. doi: 10.1182/blood.2024025102.
Blood. 2025.
PMID: 40073369